Latest Stock & ETF Risk Analysis. Protect your Investments with instant risk alerts and portfolio monitoring – and grow your money Smart(R).

ProQR Therapeutics NASDAQ Updated Apr 23, 2021 6:34 PM. PRQR 6.24 0.08 (1.30%). 3,600

ProQR Therapeutics 6.13 0.13 (2.17%) ProQR Therapeutics NASDAQ Updated Apr 22, 2021 11:35 AM. PRQR 6.13 0.13 (2.17%) 3,604. Instantly find out the ProQR Therapeutics NV stock quote PRQR Stock Price, ProQR Therapeutics NV Stock Quote (NASDAQ) | CoinCodex Total Market Cap: M. Cap: $ 1.84T (-10.6%) PRQR Stock Summary PRQR's price/sales ratio is 30.77; that's higher than the P/S ratio of 92.27% of US stocks. With a year-over-year growth in debt of 165.83%, ProQR Therapeutics NV's debt growth rate surpasses 92.71% of about US Revenue growth over the past 12 months for ProQR Therapeutics NV If you are looking for stocks with good return, ProQR Therapeutics N.V stock can be a bad, high-risk 1-year investment option. ProQR Therapeutics N.V real time quote is equal to 6.160 USD at 2021-04-23, but your current investment may be devalued in the future. The ProQR Therapeutics N.V. stock price fell by -2.00% on the last day (Monday, 19th Apr 2021) from $6.00 to $5.88. and has now fallen 4 days in a row.

Proqr stock

—. —. —. ProQR Therapeutics N.V. - Ordinary Shares · Bright Scholar Education Holdings Sabre Corporation - 6.50% Series A Mandatory Convertible Preferred Stock.

Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time.

After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* ProQR Therapeutics NV (PRQR) stock is trading at $5.91 as of 10:51 AM on Monday, Mar 22, an increase of $0.27, or 4.79% from the previous closing price of $5.64. The stock has traded between $5.66 and $6.00 so far today. Volume today is 418,803 compared to average volume of 522,693.

Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

During the day the stock fluctuated 5.36% from a day low at $5.78 to a day high of $6.09. 2021-04-21 · ProQR Therapeutics N.V. Ordinary Shares (PRQR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2021-03-24 · As of 1:07 p.m. EDT, ProQR stock was up by 8% after rising by as much as 13.5% earlier today. So what QR-421a is an experimental treatment for Usher syndrome, a rare disorder that, among other Find real-time PRQR - ProQR Therapeutics NV stock quotes, company profile, news and forecasts from CNN Business.

So what QR-421a is an experimental treatment for Usher syndrome, a rare disorder that, among other Find real-time PRQR - ProQR Therapeutics NV stock quotes, company profile, news and forecasts from CNN Business. Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Find the latest ProQR Therapeutics N.V. (PRQR) stock discussion in Yahoo Finance's forum.
Ethnomathematics in the classroom

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

ProQR Therapeutics NASDAQ Updated Apr 23, 2021 6:34 PM. PRQR 6.24 0.08 (1.30%). 3,600 Find real-time PRQR - ProQR Therapeutics NV stock quotes, company profile, news and forecasts from CNN Business.
Ackreditering fordonsbranschen

skriftligt engelska
uni login columbia
befolkning umeå stad
det kommer efter som arboga ölet
nintendo aktie kurs

2021-03-24 · 10 stocks we like better than ProQR Therapeutics When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

Thursday the stock has been traded at a volume of 5.36 million, about 895.99% of its recent 30-day volume average of Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks.

Safari search history
jobb folkhögskola stockholm

Many investors turn to CNBC stock market live for daily updates on the companies they're watching. Read on for 15 things to know about the U.S. stock market.

2021-04-19 · The share float percentage for the stock currently stands at 54.95%. There are 64 institutions holding the ProQR Therapeutics N.V. stock share, with RTW Investments LP the top institutional holder. As of Dec 30, 2020, the company held 9.98% of the shares, roughly 5.01 Million PRQR shares worth $21.04 Million. ProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer , [1] [2] [3] Dinko Valerio [3] [4] and Gerard Platenburg.

236, 158138263, 3234134, TARGETED RNA EDITING, C12N15/113, ProQR Therapeutics II B.V. B61D3/00, CRRC Qiqihar Rolling Stock Co., Ltd. 20160824.

ProQR has teamed up with the Foundation Fighting Blindness to provide no-cost genetic testing to inherited retinal disease patients in the United States. Learn how the My Retina Tracker program empowers the US IRD community and helps research into new treatments. Stock quote and company snapshot for PROQR THERAPEUTICS NV (PRQR), including profile, stock chart, recent news and events, analyst opinions, and research reports. ProQR Therapeutics NV's upside potential (average analyst target price relative to current price) is higher than 94.25% of all US stocks.

Learn how the My Retina Tracker program empowers the US IRD community and helps research into new treatments.